SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-008834
Filing Date
2020-07-31
Accepted
2020-07-31 08:44:20
Documents
79
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20200630x10q.htm   iXBRL 10-Q 1574497
2 EX-31.1 ampe-20200630xex31d1.htm EX-31.1 15526
3 EX-31.2 ampe-20200630xex31d2.htm EX-31.2 15535
4 EX-32.1 ampe-20200630xex32d1.htm EX-32.1 8070
5 GRAPHIC ampe-20200630x10q002.jpg GRAPHIC 2119
  Complete submission text file 0001558370-20-008834.txt   7164724

Data Files

Seq Description Document Type Size
6 EX-101.SCH ampe-20200630.xsd EX-101.SCH 58131
7 EX-101.CAL ampe-20200630_cal.xml EX-101.CAL 45204
8 EX-101.DEF ampe-20200630_def.xml EX-101.DEF 182364
9 EX-101.LAB ampe-20200630_lab.xml EX-101.LAB 392234
10 EX-101.PRE ampe-20200630_pre.xml EX-101.PRE 347483
11 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20200630x10q_htm.xml XML 1507769
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 201063754
SIC: 2834 Pharmaceutical Preparations